Resultados de procura - Underbayev, Chingiz
- Mostrando 1 - 14 Resultados de 14
-
1
-
2
-
3
-
4
Reversible Mitochondrial DNA Accumulation in Nuclei of Pluripotent Stem Cells por Schneider, Joel S., Cheng, Xin, Zhao, Qingshi, Underbayev, Chingiz, Gonzalez, J. Patrick, Raveche, Elizabeth S., Fraidenraich, Diego, Ivessa, Andreas S.
Publicado 2014Text -
5
IKAP—Identifying K mAjor cell Population groups in single-cell RNA-sequencing analysis por Chen, Yun-Ching, Suresh, Abhilash, Underbayev, Chingiz, Sun, Clare, Singh, Komudi, Seifuddin, Fayaz, Wiestner, Adrian, Pirooznia, Mehdi
Publicado 2019Text -
6
-
7
Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL) por Kasar, Siddha, Underbayev, Chingiz, Hassan, Moinuddin, Ilev, Ilko, Degheidy, Heba, Bauer, Steven, Marti, Gerald, Lutz, Carol, Raveche, Elizabeth, Batish, Mona
Publicado 2016Text -
8
Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia por Underbayev, Chingiz, Kasar, Siddha, Ruezinsky, William, Degheidy, Heba, Schneider, Joel Solomon, Marti, Gerald, Bauer, Steven R., Fraidenraich, Diego, Lightfoote, Marilyn M., Parashar, Vijay, Raveche, Elizabeth, Batish, Mona
Publicado 2016Text -
9
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era por Robinson, Hannah R., Qi, Junpeng, Cook, Erika M., Nichols, Cydney, Dadashian, Eman L., Underbayev, Chingiz, Herman, Sarah E. M., Saba, Nakhle S., Keyvanfar, Keyvan, Sun, Clare, Ahn, Inhye E., Baskar, Sivasubramanian, Rader, Christoph, Wiestner, Adrian
Publicado 2018Text -
10
MALT1 inhibition is efficacious in both naïve and ibrutinib-resistant chronic lymphocytic leukemia por Saba, Nakhle S., Wong, Deanna H., Tanios, Georges, Iyer, Jessica R., Lobelle-Rich, Patricia, Dadashian, Eman L., Liu, Delong, Fontan, Lorena, Flemington, Erik K., Nichols, Cydney M., Underbayev, Chingiz, Safah, Hana, Melnick, Ari, Wiestner, Adrian, Herman, Sarah E. M.
Publicado 2017Text -
11
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma por Saba, Nakhle S., Liu, Delong, Herman, Sarah E. M., Underbayev, Chingiz, Tian, Xin, Behrend, David, Weniger, Marc A., Skarzynski, Martin, Gyamfi, Jennifer, Fontan, Lorena, Melnick, Ari, Grant, Cliona, Roschewski, Mark, Navarro, Alba, Beà, Sílvia, Pittaluga, Stefania, Dunleavy, Kieron, Wilson, Wyndham H., Wiestner, Adrian
Publicado 2016Text -
12
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia por Ahn, Inhye E., Underbayev, Chingiz, Albitar, Adam, Herman, Sarah E. M., Tian, Xin, Maric, Irina, Arthur, Diane C., Wake, Laura, Pittaluga, Stefania, Yuan, Constance M., Stetler-Stevenson, Maryalice, Soto, Susan, Valdez, Janet, Nierman, Pia, Lotter, Jennifer, Xi, Liqiang, Raffeld, Mark, Farooqui, Mohammed, Albitar, Maher, Wiestner, Adrian
Publicado 2017Text -
13
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy por Landau, Dan A., Sun, Clare, Rosebrock, Daniel, Herman, Sarah E. M., Fein, Joshua, Sivina, Mariela, Underbayev, Chingiz, Liu, Delong, Hoellenriegel, Julia, Ravichandran, Sarangan, Farooqui, Mohammed Z. H., Zhang, Wandi, Cibulskis, Carrie, Zviran, Asaf, Neuberg, Donna S., Livitz, Dimitri, Bozic, Ivana, Leshchiner, Ignaty, Getz, Gad, Burger, Jan A., Wiestner, Adrian, Wu, Catherine J.
Publicado 2017Text -
14
MARCKS affects cell motility and response to BTK inhibitors in CLL por Beckmann, Laura, Berg, Valeska, Dickhut, Clarissa, Sun, Clare, Merkel, Olaf, Bloehdorn, Johannes, Robrecht, Sandra, Seifert, Marc, da Palma Guerreiro, Alexandra, Claasen, Julia, Loroch, Stefan, Oliverio, Matteo, Underbayev, Chingiz, Vaughn, Lauren, Thomalla, Daniel, Hülsemann, Malte F., Tausch, Eugen, Fischer, Kirsten, Fink, Anna Maria, Eichhorst, Barbara, Sickmann, Albert, Wendtner, Clemens M., Stilgenbauer, Stephan, Hallek, Michael, Wiestner, Adrian, Zahedi, René P., Frenzel, Lukas P.
Publicado 2021Text